Why Specimen Integrity Fails Before It Ever Reaches the Lab
Every diagnostic result begins with a sample. A tube of blood, a swab, a tissue biopsy, a urine collection. By the time that sample reaches the analysing instrument inside a laboratory, it has passed through multiple hands, survived a journey of varying distance, and endured conditions that most clinicians never think about. And in a significant number of cases, something has already gone wrong.
Specimen integrity , the degree to which a biological sample accurately represents the patient’s
physiological state at the time of collection , is one of the most consequential and least discussed
variables in diagnostic medicine. When it fails, the consequences ripple outward quietly. A result is
rejected. A test is repeated. A clinician makes a decision based on data that no longer reflects reality.
The question worth asking is: where does it actually go wrong?
The Pre-Analytical Phase Carries the Most Risk
Laboratory professionals divide the diagnostic process into three phases: pre-analytical, analytical, and post-analytical. Of the three, the pre-analytical phase , everything that happens before the sample reaches the instrument , accounts for the overwhelming majority of diagnostic errors. Estimates in international literature place this figure at somewhere between 46% and 68% of all laboratory mistakes.
The analytical phase, by contrast, is tightly controlled. Modern laboratory instruments are calibrated, validated, and monitored continuously. Quality assurance programmes in accredited laboratories are rigorous. The science inside the lab has largely been solved. What happens outside the lab is a different
matter entirely
The pre-analytical phase encompasses patient preparation, sample collection, labelling, handling, storage, and transport. Each of these steps introduces variables that the laboratory has limited ability to control, and limited visibility over. A sample can arrive at a facility looking entirely normal on the outside while its cellular and chemical composition has already shifted in ways that will produce a misleading result.
Haemolysis: The Most Common and Costly Form of Degradation
Among the forms of specimen degradation that affect diagnostic accuracy, haemolysis is the most frequently encountered. It occurs when red blood cells rupture and release their intracellular contents, primarily haemoglobin, potassium, and lactate dehydrogenase, into the surrounding serum or plasma. The result is a sample that appears visibly pink or red, and one that will produce falsely elevated readings for a range of analytes including potassium, magnesium, aspartate aminotransferase, and lactate
dehydrogenase
Temperature Excursions and What They Do to a Sample
Different specimen types have different thermal tolerances, and managing these tolerances during transport requires deliberate design, not improvisation. Whole blood collected for haematological analysis is generally stable at room temperature for a limited window, typically four to six hours for most parameters, with platelet counts becoming unreliable sooner. Coagulation specimens , citrate tubes used for PT, APTT, and fibrinogen , are particularly sensitive and should neither be refrigerated nor exposed to
heat.
When specimens are transported in conditions that fall outside their required parameters , in an unmonitored vehicle, in a bag left on a car seat in summer heat, or in a cooler box packed without validated temperature confirmation, what arrives at the laboratory may be chemically and biologically different from what left the patient.
Time: The Variable Everyone Underestimates
This means that every minute between collection and analysis has clinical weight. A specimen collected at 08:00 that arrives at a laboratory at 14:00 , because a collection round was delayed, because a courier was unavailable, because no one had a system for prioritising pickups, has lost ground it cannot recover. Laboratories operating in high-volume environments like Johannesburg depend on predictable,timely transport not as a logistical preference, but as a clinical necessity.
The Chain of Custody Gap
There is another dimension to specimen integrity that sits alongside the physical one: the documentary record. Chain of custody refers to the chronological trail that accounts for a specimen’s possession, location, and condition from collection to result. In medico-legal cases, this trail is legally required. In clinical diagnostics more broadly, it is a quality indicator, one that allows a laboratory to reconstruct what
happened to a sample if a result is questioned or a rejection is disputed.
Gaps in this record create real problems. If a specimen arrives degraded and there is no timestamp for pickup, no temperature log from transit, and no documented handover at collection, the laboratory cannot determine where the failure occurred. The clinician cannot be given a meaningful explanation. And the patient, who may be waiting on a result that drives a treatment decision , remains in diagnostic limbo. An unbroken chain of custody, timestamped at every handover and supported by a GPS route record, turns a logistical process into an accountable clinical one.
What the Laboratory Sees That the Clinic Doesn't
When a specimen arrives at a laboratory, it undergoes visual inspection before it reaches an instrument. Technicians assess for haemolysis, lipaemia, and icterus. They check for clotting in tubes that should be free of clots. They verify labelling, volume adequacy, and tube type. Rejection rates, the proportion of received specimens that cannot be processed as submitted, vary between facilities, but rates above 1-2% are considered indicative of upstream problems.
High rejection rates cost laboratories time. They cost clinicians turnaround time. They cost patients the clarity they came to the healthcare system to find. Most of those upstream problems are not analytical. They are pre-analytical. And a meaningful portion of them are transport-related, not collection-related.
